However currently the role of OPG and its relationship with chronic inflammatory markers in T2D patients affecting by PAD remains unclear, largely unexplored in experimental and clinical investigations, considering that there are some frequently ignored aspects like polyvascular atherosclerosis which might influence OPG levels [19]. The gene discussed is TNFRSF11B; the disease is peripheral arterial disease.